How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Summary of key evidence on CARTO for gastric varices

    Study 8 Yamamoto A (2020)

    Study details

    Study type

    Retrospective, single centre, case series

    Country

    Japan

    Recruitment period

    2016 to 2018

    Study population and number

    n=36

    Consecutive people with gastric varices who had CARTO-II (see Technique below)

    Age and sex

    Mean 64.7 years; 56% male

    Patient selection criteria

    Consecutive people with gastric varices who had CARTO-II.

    People were excluded for: emergent BRTO (n=3), high wedge pressure of the hepatic vein (45 mmHg) after temporary occlusion of the gastrorenal shunt (n=1), did not undergo BRTO because of visualisation of apparent portopulmonary vein anastomosis during the procedure (n=1).

    Technique

    CARTO-II is a modified BRTO technique in which coils and a balloon catheter are used.

    Under local anaesthesia, a balloon catheter is inserted into the gastrorenal shunt. Venography was performed to visualise the varices. Ethanolamine oleate and iopamidol was used to embolise the varices. Then, coil embolisation of the drainage vein was performed through the balloon catheter.

    Follow up

    Mean 207 days (range 3 to 675 days)

    Conflict of interest/source of funding

    Conflict of interest: The authors declare that they have no conflict of interest.

    Source of funding: Not reported.

    Analysis

    Study design issues: This retrospective case series assessed the outcomes of a modified CARTO procedure, CARTO-II, for the treatment of gastric varices. Consecutive people were identified retrospectively from medical records. Outcomes included:

    • Technical success, defined as blood flow stagnation on venograms obtained immediately after final balloon deflation.

    • Clinical success, defined as absence of recurrence after CARTO-II.

    • Survival.

    • Complications.

    No statistical analysis was performed.

    Study population issues: The aetiology was alcohol in 13 (36%), non-alcoholic fatty liver disease in 7 (19%), hepatitis B in 5 (14%), hepatitis C in 4 (11%), Fontan-associated liver disease in 1 (3%), primary biliary cirrhosis in 1 (3%), Wilson disease in 1 (3%), extra-hepatic portal vein obstruction in 1 (3%), and unknown in 3 (8%). There were 28 people classified as Child-Pugh grade A and 8 as grade B. The form of gastric varices was F1 in 1 person (2%), F2 in 29 (82%), and F3 in 6 (16%). The Hirota grade of varices was 1 in 5 people (14%), 2 in 12 (33%), 3 in 11 (31%), and 4 in 8 (22%).

    Key efficacy findings

    Technical success

    Number of people analysed: 36

    • The technical success rate was 100% (36/36).

    Clinical success

    Number of people analysed: 36

    • The clinical success rate was 97.2% (35/36).

      • One person experienced recurrence of varices in the follow up period.

    Survival

    Number of people analysed: 36

    • All people survived the follow-up period.

    Key safety findings

    Complications

    Number of people analysed: 36

    No severe complications were observed.